MILTENYI BIOTEC

Miltenyi Bioindustry supports all efforts, from pre-clinical to commercial scale, as a full-service provider for the development and manufacturing of lentiviral vectors (LVVs) and cell and gene therapy (CGT) products. As a globally active CDMO (Contract Development and Manufacturing Organization) with over 30 years of extensive know-how, we are helping to shape this rapidly growing arena. We leverage the latest technology platforms to make your vision of commercial-scale manufacturing a reality. We are a division of Miltenyi Biotec, a pioneering innovator and provider of cell processing and analytical platforms, LVVs, and ancillary materials in this field... Our commitment to making new therapies a reality began with the development of the CliniMACS® Plus Instrument, the world's first automated cell separation device, and led to the FDA approval of the CliniMACS® CD34 Reagent System. The launch of the fully automated CliniMACS Prodigy® Platform set the standard for automated,..

Also known as: Miltenyi Bioindustry, Miltenyi Biotec, Inc.

Registration numbers: HRA 34194 (W)

VAT numbers: DE815828586

Primary location: Bergisch Gladbach Germany